help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, C. C.
Right arrow Articles by Shapiro, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, C. C.
Right arrow Articles by Shapiro, D. J.
Molecular Endocrinology 13 (4): 632-643
Copyright © 1999 by The Endocrine Society

HMG-1 Stimulates Estrogen Response Element Binding by Estrogen Receptor from Stably Transfected HeLa Cells

Cheng Cheng Zhang, Sacha Krieg and David J. Shapiro

Department of Biochemistry University of Illinois Urbana, Illinois 61801

Estrogen receptor (ER) toxicity has hampered the development of vertebrate cell lines stably expressing substantial levels of recombinant wild-type ER. To isolate clonal lines of HeLa cells stably expressing epitope-tagged ER, we used a construction encoding a single bicistronic mRNA, in which FLAG-epitope-tagged human ER{alpha} (fER) was translated from a 5'-translation initiation site and fused to the neomycin resistance gene, which was translated from an internal ribosome entry site. One stable HeLa-ER-positive cell line (HeLa-ER1) produces 1,300,000 molecules of fER/cell (~20-fold more ER than MCF-7 cells). The HeLa fER is biologically active in vivo, as judged by rapid death of the cells in the presence of either 17ß-estradiol or trans-hydroxytamoxifen and the ability of the cell line to activate a transfected estrogen response element (ERE)-containing reporter gene. The FLAG-tagged ER was purified to near homogeneity in a single step by immunoaffinity chromatography with anti-FLAG monoclonal antibody. Purified fER exhibited a distribution constant (KD) for 17ß-estradiol of 0.45 nM. Purified HeLa fER and HeLa fER in crude nuclear extracts exhibit similar KD values for the ERE (0.8 nM and 1 nM, respectively), which are approximately 10 times lower than the KD of 10 nM we determined for purified ER expressed using the baculovirus system. HMG-1 strongly stimulated binding of both crude and purified HeLa fER to the ERE (KD of 0.25 nM). In transfected HeLa cells, HMG-1 exhibited a dose-dependent stimulation of 17ß-estradiol-dependent transactivation. At high levels of transfected HMG-1 expression plasmid, transactivation by ER became partially ligand-independent, and transactivation by trans-hydroxytamoxifen was increased by more than 25-fold. These data describe a system in which ER, stably expressed in HeLa cells and easily purified, exhibits extremely high affinity for the ERE, and suggest that intracellular levels of HMG-1 may be limiting for ER action.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. K. Hill, S. C. Roemer, D. N. M. Jones, M. E. A. Churchill, and D. P. Edwards
A Progesterone Receptor Co-activator (JDP2) Mediates Activity through Interaction with Residues in the Carboxyl-terminal Extension of the DNA Binding Domain
J. Biol. Chem., September 4, 2009; 284(36): 24415 - 24424.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. C. Roemer, J. Adelman, M. E. A. Churchill, and D. P. Edwards
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding
Nucleic Acids Res., June 1, 2008; 36(11): 3655 - 3666.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. P. Fink
Neuropeptide Modulators of High Mobility Group Box 1 Secretion as Potential Therapeutic Agents for Severe Sepsis
Am. J. Pathol., May 1, 2008; 172(5): 1171 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. D. Curtis, V. S. Likhite, I. X. McLeod, J. R. Yates, and A. M. Nardulli
Interaction of the Tumor Metastasis Suppressor Nonmetastatic Protein 23 Homologue H1 and Estrogen Receptor {alpha} Alters Estrogen-Responsive Gene Expression
Cancer Res., November 1, 2007; 67(21): 10600 - 10607.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cheng, D. V. Yu, J.-H. Zhou, and D. J. Shapiro
Tamoxifen Induction of CCAAT Enhancer-binding Protein {alpha} Is Required for Tamoxifen-induced Apoptosis
J. Biol. Chem., October 19, 2007; 282(42): 30535 - 30543.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Cheng, C. Zhang, and D. J. Shapiro
A Functional Serine 118 Phosphorylation Site in Estrogen Receptor-{alpha} Is Required for Down-Regulation of Gene Expression by 17{beta}-Estradiol and 4-Hydroxytamoxifen
Endocrinology, October 1, 2007; 148(10): 4634 - 4641.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Wang, C. Zhang, S. K. Nordeen, and D. J. Shapiro
In Vitro Fluorescence Anisotropy Analysis of the Interaction of Full-length SRC1a with Estrogen Receptors {alpha} and beta Supports an Active Displacement Model for Coregulator Utilization
J. Biol. Chem., February 2, 2007; 282(5): 2765 - 2775.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. C. Roemer, D. C. Donham, L. Sherman, V. H. Pon, D. P. Edwards, and M. E. A. Churchill
Structure of the Progesterone Receptor-Deoxyribonucleic Acid Complex: Novel Interactions Required for Binding to Half-Site Response Elements
Mol. Endocrinol., December 1, 2006; 20(12): 3042 - 3052.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. F. Eddy, S. Guo, E. G. Demicco, R. Romieu-Mourez, E. Landesman-Bollag, D. C. Seldin, and G. E. Sonenshein
Inducible I{kappa}B Kinase/I{kappa}B Kinase {varepsilon} Expression Is Induced by CK2 and Promotes Aberrant Nuclear Factor-{kappa}B Activation in Breast Cancer Cells
Cancer Res., December 15, 2005; 65(24): 11375 - 11383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Das, R. C. Peterson, and W. M. Scovell
High Mobility Group B Proteins Facilitate Strong Estrogen Receptor Binding to Classical and Half-Site Estrogen Response Elements and Relax Binding Selectivity
Mol. Endocrinol., November 1, 2004; 18(11): 2616 - 2632.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. A. Loven, R. E. Davis, C. D. Curtis, N. Muster, J. R. Yates, and A. M. Nardulli
A Novel Estrogen Receptor {alpha}-Associated Protein Alters Receptor-Deoxyribonucleic Acid Interactions and Represses Receptor-Mediated Transcription
Mol. Endocrinol., November 1, 2004; 18(11): 2649 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. S. Melvin, C. Harrell, J. S. Adelman, W. L. Kraus, M. Churchill, and D. P. Edwards
The Role of the C-terminal Extension (CTE) of the Estrogen Receptor {alpha} and {beta} DNA Binding Domain in DNA Binding and Interaction with HMGB
J. Biol. Chem., April 9, 2004; 279(15): 14763 - 14771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Krieg, S. A. Krieg, B. S. Ahn, and D. J. Shapiro
Interplay between Estrogen Response Element Sequence and Ligands Controls in Vivo Binding of Estrogen Receptor to Regulated Genes
J. Biol. Chem., February 6, 2004; 279(6): 5025 - 5034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Amir, M. Barua, N. C. McKnight, S. Cheng, X. Yuan, and S. P. Balk
A Direct {beta}-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4
J. Biol. Chem., August 15, 2003; 278(33): 30828 - 30834.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. A. Loven, N. Muster, J. R. Yates, and A. M. Nardulli
A Novel Estrogen Receptor {alpha}-Associated Protein, Template-Activating Factor I{beta}, Inhibits Acetylation and Transactivation
Mol. Endocrinol., January 1, 2003; 17(1): 67 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Obrero, D. V. Yu, and D. J. Shapiro
Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell Death
J. Biol. Chem., November 15, 2002; 277(47): 45695 - 45703.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. S. Melvin, S. C. Roemer, M. E. A. Churchill, and D. P. Edwards
The C-terminal Extension (CTE) of the Nuclear Hormone Receptor DNA Binding Domain Determines Interactions and Functional Response to the HMGB-1/-2 Co-regulatory Proteins
J. Biol. Chem., July 5, 2002; 277(28): 25115 - 25124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Yuan, M. L. Lu, T. Li, and S. P. Balk
SRY Interacts with and Negatively Regulates Androgen Receptor Transcriptional Activity
J. Biol. Chem., November 30, 2001; 276(49): 46647 - 46654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. WANG, H. YANG, C. J. CZURA, A. E. SAMA, and K. J. TRACEY
HMGB1 as a Late Mediator of Lethal Systemic Inflammation
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1768 - 1773.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. A. Krieg, A. J. Krieg, and D. J. Shapiro
A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1{beta}- Converting Enzyme (Caspase 1)
Mol. Endocrinol., November 1, 2001; 15(11): 1971 - 1982.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C. J. Czura, Haichao Wang, and K. J. Tracey
Dual roles for HMGB1: DNA binding and cytokine
Innate Immunity, August 1, 2001; 7(4): 315 - 321.
[Abstract] [PDF]


Home page
Cancer Res.Home page
S. Oesterreich, P. Zhang, R. L. Guler, X. Sun, E. M. Curran, W. V. Welshons, C. K. Osborne, and A. V. Lee
Re-expression of Estrogen Receptor {alpha} in Estrogen Receptor {alpha}-negative MCF-7 Cells Restores both Estrogen and Insulin-like Growth Factor-mediated Signaling and Growth
Cancer Res., August 1, 2001; 61(15): 5771 - 5777.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. M. Klinge
Estrogen receptor interaction with estrogen response elements
Nucleic Acids Res., July 15, 2001; 29(14): 2905 - 2919.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. R. Drew, D. C. Tang, P. E. Berg, and G. P. Rodgers
The role of trans-acting factors and DNA-bending in the silencing of human {beta}-globin gene expression
Nucleic Acids Res., July 15, 2000; 28(14): 2823 - 2830.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Mao and D. J. Shapiro
A Histone Deacetylase Inhibitor Potentiates Estrogen Receptor Activation of a Stably Integrated Vitellogenin Promoter in HepG2 Cells
Endocrinology, July 1, 2000; 141(7): 2361 - 2369.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. B. Ellwood, Y.-M. Yen, R. C. Johnson, and M. Carey
Mechanism for Specificity by HMG-1 in Enhanceosome Assembly
Mol. Cell. Biol., June 15, 2000; 20(12): 4359 - 4370.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
D. Knutti, A. Kaul, and A. Kralli
A Tissue-Specific Coactivator of Steroid Receptors, Identified in a Functional Genetic Screen
Mol. Cell. Biol., April 1, 2000; 20(7): 2411 - 2422.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Kanamori, S. Krieg, C. Mao, V. A. Di Pippo, S. Wang, D. A. Zajchowski, and D. J. Shapiro
Proteinase Inhibitor 9, an Inhibitor of Granzyme B-mediated Apoptosis, Is a Primary Estrogen-inducible Gene in Human Liver Cells
J. Biol. Chem., February 25, 2000; 275(8): 5867 - 5873.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. Zhang and D. J. Shapiro
Activation of the p38 Mitogen-activated Protein Kinase Pathway by Estrogen or by 4-Hydroxytamoxifen Is Coupled to Estrogen Receptor-induced Apoptosis
J. Biol. Chem., January 7, 2000; 275(1): 479 - 486.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. He, C. H. Liang, and S. J. Lippard
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
PNAS, May 23, 2000; 97(11): 5768 - 5772.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society